|
2015 |
Perimenopause as a neurological transition state. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2015 |
A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors. |
Rajesh Khanna, May Khanna, PhD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2015 |
The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2015 |
Therapeutic potential of peroxynitrite decomposition catalysts: a patent review. |
Todd Vanderah, PhD |
|
2015 |
Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors. |
Yeon Sun Lee, Frank Porreca, PhD |
|
2015 |
Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. |
Patrick W Mantyh |
|
2015 |
Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. |
John M. Streicher, PhD |
|
2015 |
Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2015 |
(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5. |
Rajesh Khanna, May Khanna, PhD |
|
2015 |
Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism. |
Patrick W Mantyh |
|
2015 |
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. |
George Watts, Ph.D. |
|
2015 |
Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6. |
George Watts, Ph.D. |
|
2015 |
Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors. |
Yeon Sun Lee, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
Use of Animal Models in Understanding Cancer-induced Bone Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2015 |
Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Temperature differentially facilitates spontaneous but not evoked glutamate release from cranial visceral primary afferents. |
Tally Largent-Milnes, PhD |
|
2014 |
Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis. |
Nam Lee, Ph.D. |
|
2014 |
Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. |
Yeon Sun Lee, Frank Porreca, PhD |
|
2014 |
Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor. |
Yeon Sun Lee |
|
2014 |
Structure-activity relationships of non-opioid [des-Arg(7)]-dynorphin A analogues for bradykinin receptors. |
Yeon Sun Lee, Frank Porreca, PhD |
|
2014 |
Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study. |
Roberta Diaz Brinton, Ph.D |
